Vimarsana
Biggest News Aggregation in the World

Marshall Wace News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Marshall Wace. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Marshall Wace Today - Breaking & Trending Today

GAM's Hawtin and team join Liontrust and form new global equity arm - Vimarsana News

GAM's Hawtin and team join Liontrust and form new global equity arm

Ewan Thompson, Tom Smith and Ruth Chambers will move internally to join the team

Is Cytokinetics, Incorporated (NASDAQ:CYTK) the Best Mid-Cap Healthcare Stock To Buy Now? - Vimarsana News

Is Cytokinetics, Incorporated (NASDAQ:CYTK) the Best Mid-Cap Healthcare Stock To Buy Now?

We recently compiled a list of the 7 Best Mid-Cap Healthcare Stocks To Buy Now and in this article we discuss whether Cytokinetics, Incorporated (NASDAQ:CYTK) is the best mid-cap healthcare stock to buy now according to hedge funds. Challenges in the Health Sector The healthcare industry is considered to be a fairly defensive sector due […]

Source: yahoo.com
Futures up; focus on inflation data - Vimarsana News

Futures up; focus on inflation data

On Tuesday, major European stock exchanges are expected to open almost all above par, with London the only one to show a bearish start to the session in the aftermath of the bank holiday break. ...

Mib rises and ECB cuts in sight; boost on Zignago - Vimarsana News

Mib rises and ECB cuts in sight; boost on Zignago

On Monday, Piazza Affari closed the session in positive territory along with other European stock markets, with the U.S. and U.K. exchanges closed for holidays, while on the monetary policy front, the...

Is Coursera, Inc. (NYSE:COUR) the Best Small Cap Stock to Buy According to Analysts? - Vimarsana News

Is Coursera, Inc. (NYSE:COUR) the Best Small Cap Stock to Buy According to Analysts?

Though Coursera, Inc. (NYSE:COUR) ranks 5th in our list, we have analyzed the stock in detail.